Point72 Asia (Singapore)’s Atea Pharmaceuticals AVIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-3,028
Closed -$10K 967
2024
Q2
$10K Sell
3,028
-2,472
-45% -$8.18K ﹤0.01% 930
2024
Q1
$22.2K Buy
+5,500
New +$22.2K 0.01% 948